BioCentury
ARTICLE | Financial News

Oncolytics raises $32 million in follow-on

February 21, 2013 1:38 AM UTC

Oncolytics Biotech Inc. (TSX:ONC; NASDAQ:ONCY) raised $32 million through the sale of 8 million shares at $4 in a follow-on underwritten by Piper Jaffray; Wedbush; and Paradigm Capital. The price is a 17% discount to Oncolytics' close of $4.67 on Tuesday, before the offering was announced. On Wednesday, Oncolytics was off C$0.76 (16%) to C$3.99. On NASDAQ, the stock was down $0.77 (17%) to $3.90. ...